1179443

REDHILL BIOPHARMA INC. — FEI 3016555114

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 25, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Raleigh, NC (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)